Aparna Pathak

Aparna Pathak is a Senior Scientist at Guardant Health since January 2025, focusing on technology development for Follow-On Companion Diagnostics (CDx). Previous roles include Senior Scientist at GRAIL, where responsibilities encompassed the MCED PMA, colorectal cancer MRD assay, and IDE application for LUAD trial support, and previous tenure at Guardant Health as Scientist II and Scientist I for liquid biopsy technology, contributing to the FDA-approved Guardant360 CDx Assay. Earlier experience includes positions at Life Technologies, Novartis, EMD Serono, and Tufts Medical Center, with a strong background in molecular biology, next-generation sequencing, and oncology diagnostics. Aparna Pathak holds an M.S. in Biotechnology from Northeastern University and a B.Tech in Biotechnology from Dr. D. Y Patil University.